Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017, New York University
Credit: CC0 Public Domain

Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

Researchers at New York University College of Dentistry (NYU Dentistry) have described a new target that may open the door to developing therapies for preventing in people with type 2 diabetes.

In a study published in Nature Communications, the investigators report that hyperglycemic (or mice with type 2 diabetes) have a 24-fold higher accumulation of succinate, an intermediate metabolite, in the metabolic pathways of their bone marrow stromal cells. In comparison, succinate was barely detectable in the normal mice. An intermediate metabolite is a compound that is both a product of one-step in a biochemical pathway or cycle, as well as the substrate for the next step.

In the study, "Succinate and its G-protein-coupled receptor stimulate osteoclastogenesis," the researchers took samples of bone marrow from hyperglycemic male mice and healthy mice. They studied the at the cellular level using advanced imaging and computational techniques, which allowed them to identify 142 metabolites that were significantly altered by more than 1.5 times in the . Of 142 metabolites, 126 were upregulated (or increased) and 16 were downregulated (or decreased).

Succinate was the first metabolite in the energy pathway, and with its more than 20-fold increased concentration, it overwhelmed the energy pathways. Additionally, the diabetic mice had considerably lower spongy bone mass, known as , making it easy to fracture.

"The bottom line is that the high level of succinate combined with the finding of more fragile bone points to a new target to protect bone," said Yuqi Guo, MD, associate research scientist at NYU Dentistry, and the study's first author.

"The results are important because diabetics have a significantly higher fracture risk and their healing process is always delayed," said Xin Li, PhD, associate professor of basic science and craniofacial biology at NYU Dentistry, and the study's senior investigator. "In our study, the hyperglycemic mice had increased [the breakdown and absorption of old bone], which outpaced the formation of new bone. This has implications for bone protection, as well as for the treatment of diabetes-associated collateral bone damage."

Dr. Guo and his team utilized a relatively new field of research called metabolomics to examine the bone marrow. The technique examines the small molecules, or metabolites, within cells, bio-fluids, tissue, or organisms and their interactions within the larger system, called a metabolome. Metabolomics is an extremely powerful tool because it can depict the underlying biochemical activity and signaling between cells and tissues. It is proving invaluable in identifying biomarkers and pinpointing potential drug targets for many diseases.

This study builds on previous research by Dr. Li's laboratory that showed, for the first time, significant accumulation of succinate in the and serum of hyperglycemic mice. It opens the door to pursuing regulating succinate for protecting in diabetics.

Diabetes affects 29.1 million Americans or 9.3% of the population in the United States, according to 2012 Centers for Disease Control and Prevention data. Bone complications, such as hip or back fractures, can be devastating. The Women's Health Initiative found that type 2 diabetes was linked to a 20% risk increase in fractures.

Explore further: Even your bones can get fat, mouse study suggests

More information: Yuqi Guo et al. Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis, Nature Communications (2017). DOI: 10.1038/ncomms15621

Related Stories

Even your bones can get fat, mouse study suggests

June 9, 2017
(HealthDay)—Exercise doesn't just trim your tummy. It may also improve bone thickness, boost bone quality, and whittle away the fat found inside bones, new animal research suggests.

Non-coding RNA molecule could play a role in osteoporosis

March 28, 2017
Researchers from Hong Kong Baptist University and colleagues have demonstrated that a molecule called miR-214-3p plays a role in inhibiting bone formation. MiR-214-3p is a microRNA (miRNA): a non-coding RNA involved in regulating ...

Scientists discover new bone-forming growth factor that reverses osteoporosis in mice

December 13, 2016
A team of scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) discovered a new bone-forming growth factor, Osteolectin (Clec11a), which reverses osteoporosis in mice and has implications ...

Researchers discover gene that slows bone loss and promotes bone formation

August 12, 2014
(Medical Xpress)—Osteoporosis and aging-related bone loss is debilitating and painful. With a greater understanding of Wnt4 signaling, researchers are now closer to developing therapeutic agents that could slow down bone ...

High blood sugar may inhibit positive effects of exercise on bone health in people with diabetes

August 24, 2015
Diabetes, which now affects almost 30 million Americans, can cause serious health complications, including heart disease, blindness, kidney failure and lower-extremity amputations.

Study provides insights on optimal treatment of Paget's disease of bone

February 8, 2017
In a study of patients with Paget's disease of bone—a common skeletal disorder that can lead to bone deformity, fractures, osteoarthritis, and bone pain—long-term intensive bisphosphonate therapy conferred no clinical ...

Recommended for you

Lentils significantly reduce blood glucose levels, study reveals

June 13, 2018
Replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 per cent, according to a first-ever University of Guelph study.

Is there a link between diabetes and Parkinson's disease?

June 13, 2018
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology, the medical journal ...

Double-checking diabetes medications may reduce re-hospitalizations

June 11, 2018
Clinicians may take upwards of 15 minutes to double-check a patient's medication list in an electronic health record system, but according to a new study, this reconciliation process may be well worth the time for diabetes ...

How a gene linked to obesity could provide new insights into diabetes

June 8, 2018
A gene previously linked with obesity has been found to affect how the body processes insulin, with potential implications for some forms of diabetes.

New hope from the 'seven year switch' in type 1 diabetes

June 8, 2018
New research has shown that the rapid decline in insulin production that causes Type 1 diabetes continues to fall over seven years and then stabilises.

Diabetes results from a breakdown of epigenetic control

June 5, 2018
Diabetes affects more than 400 million individuals worldwide. In what is becoming a paradigm shift, researchers have begun to find that the disease may result in part through pancreatic beta cells losing their functional ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.